Lista de obras - Stephane Loyau - Dominio Público Uruguay

A humanized glycoprotein VI (GPVI) mouse model to assess the antithrombotic efficacies of anti-GPVI agents.

artículo científico publicado en 2012

A novel kringle-4 number-based recombinant apo[a] standard for human apo[a] phenotyping.

artículo científico publicado en 1999

Alteplase Reduces Downstream Microvascular Thrombosis and Improves the Benefit of Large Artery Recanalization in Stroke.

artículo científico publicado en 2015

An acquired inhibitor to the GPVI platelet collagen receptor in a patient with lupus nephritis.

artículo científico publicado en 2009

Antibodies to fibrin bound tissue type plasminogen activator in systemic sclerosis

scientific article published on 01 September 1995

Antibodies to fibrin-bound tissue-type plasminogen activator in systemic lupus erythematosus are associated with Raynaud's phenomenon and thrombosis

scientific article published on 01 August 1996

Binding of recombinant apolipoprotein(a) to human platelets and effect on platelet aggregation

artículo científico publicado en 2001

Chimeric Fc Receptors Identify Ligand Binding Regions in Human Glycoprotein VI

scientific article published on 07 July 2006

Collagen can selectively trigger a platelet secretory phenotype via glycoprotein VI.

artículo científico publicado en 2014

Design and reshaping of an scFv directed against human platelet glycoprotein VI with diagnostic potential

artículo científico publicado en 2011

Does apolipoprotein(a) heterogeneity influence lipoprotein(a) effects on fibrinolysis?

artículo científico publicado en 1993

Effect of individual plasma lipoprotein(a) variations in vivo on its competition with plasminogen for fibrin and cell binding: An in vitro study using plasma from children with idiopathic nephrotic syndrome.

artículo científico publicado en 2000

Evidence that modifications of Lp(a) in vivo inhibit plasmin formation on fibrin--a study with individual plasmas presenting natural variations of Lp(a)

artículo científico publicado en 1999

Ex vivo inhibition of thrombus formation by an anti-glycoprotein VI Fab fragment in non-human primates without modification of glycoprotein VI expression

artículo científico publicado en 2008

Familial association of high levels of histidine-rich glycoprotein and plasminogen activator inhibitor-1 with venous thromboembolism

artículo científico publicado en 1993

Fibrino(geno)lytic properties of purified hementerin, a metalloproteinase from the leech Haementeria depressa.

artículo científico publicado en 1998

Functional approach to investigate Lp(a) in ischaemic heart and cerebral diseases

artículo científico publicado en 2003

Inhibition of Glycoprotein VI Clustering by Collagen as a Mechanism of Inhibiting Collagen-Induced Platelet Responses: The Example of Losartan

artículo científico publicado en 2015

Inhibition of fibrinolysis by lipoprotein(a).

artículo científico publicado en 2001

Kringles of the plasminogen--prothrombin gene family share conformational epitopes with recombinant apolipoprotein (a): specificity of the fibrin-binding site

artículo científico publicado en 2001

Lp(a) particles mold fibrin-binding properties of apo(a) in size-dependent manner: a study with different-length recombinant apo(a), native Lp(a), and monoclonal antibody.

artículo científico publicado en 2002

Modulation of protease nexin-1 activity by polysaccharides

artículo científico publicado en 2006

Molecular assembly of plasminogen and tissue-type plasminogen activator on an evolving fibrin surface

artículo científico publicado en 1993

Non-invasive molecular imaging of fibrosis using a collagen-targeted peptidomimetic of the platelet collagen receptor glycoprotein VI

artículo científico publicado en 2009

Platelet Glycoprotein VI Dimerization, an Active Process Inducing Receptor Competence, Is an Indicator of Platelet Reactivity

artículo científico publicado en 2012

Platelet Protease Nexin-1, a Serpin That Strongly Influences Fibrinolysis and Thrombolysis ⬇️

artículo científico publicado el 14 de marzo de 2011

Role of vegetation-associated protease activity in valve destruction in human infective endocarditis.

artículo científico publicado en 2012

Single platelets seal neutrophil-induced vascular breaches via GPVI during immune-complex-mediated inflammation in mice.

artículo científico publicado en 2015

Structure and properties of clots from fibrinogen Bicêtre II (gamma 308 Asn-->Lys). Increased permeability due to larger pores, thicker fibers, and decreased rigidity

artículo científico publicado en 2001

The future of glycoprotein VI as an antithrombotic target.

artículo científico

Topology of protease activities reflects atherothrombotic plaque complexity

scientific article published on 19 May 2006

Upholding the T cell immune-regulatory function of CD31 inhibits the formation of T/B immunological synapses in vitro and attenuates the development of experimental autoimmune arthritis in vivo

artículo científico publicado en 2014

[Antithrombotic recombinant antibodies]

scientific article published on 01 January 2006

Lista de obras de Stephane Loyau

A humanized glycoprotein VI (GPVI) mouse model to assess the antithrombotic efficacies of anti-GPVI agents.

A novel kringle-4 number-based recombinant apo[a] standard for human apo[a] phenotyping.

Alteplase Reduces Downstream Microvascular Thrombosis and Improves the Benefit of Large Artery Recanalization in Stroke.

An acquired inhibitor to the GPVI platelet collagen receptor in a patient with lupus nephritis.

Antibodies to fibrin bound tissue type plasminogen activator in systemic sclerosis

Antibodies to fibrin-bound tissue-type plasminogen activator in systemic lupus erythematosus are associated with Raynaud's phenomenon and thrombosis

Binding of recombinant apolipoprotein(a) to human platelets and effect on platelet aggregation

Chimeric Fc Receptors Identify Ligand Binding Regions in Human Glycoprotein VI

Collagen can selectively trigger a platelet secretory phenotype via glycoprotein VI.

Design and reshaping of an scFv directed against human platelet glycoprotein VI with diagnostic potential

Does apolipoprotein(a) heterogeneity influence lipoprotein(a) effects on fibrinolysis?

Effect of individual plasma lipoprotein(a) variations in vivo on its competition with plasminogen for fibrin and cell binding: An in vitro study using plasma from children with idiopathic nephrotic syndrome.

Evidence that modifications of Lp(a) in vivo inhibit plasmin formation on fibrin--a study with individual plasmas presenting natural variations of Lp(a)

Ex vivo inhibition of thrombus formation by an anti-glycoprotein VI Fab fragment in non-human primates without modification of glycoprotein VI expression

Familial association of high levels of histidine-rich glycoprotein and plasminogen activator inhibitor-1 with venous thromboembolism

Fibrino(geno)lytic properties of purified hementerin, a metalloproteinase from the leech Haementeria depressa.

Functional approach to investigate Lp(a) in ischaemic heart and cerebral diseases

Inhibition of Glycoprotein VI Clustering by Collagen as a Mechanism of Inhibiting Collagen-Induced Platelet Responses: The Example of Losartan

Inhibition of fibrinolysis by lipoprotein(a).

Kringles of the plasminogen--prothrombin gene family share conformational epitopes with recombinant apolipoprotein (a): specificity of the fibrin-binding site

Lp(a) particles mold fibrin-binding properties of apo(a) in size-dependent manner: a study with different-length recombinant apo(a), native Lp(a), and monoclonal antibody.

Modulation of protease nexin-1 activity by polysaccharides

Molecular assembly of plasminogen and tissue-type plasminogen activator on an evolving fibrin surface

Non-invasive molecular imaging of fibrosis using a collagen-targeted peptidomimetic of the platelet collagen receptor glycoprotein VI

Platelet Glycoprotein VI Dimerization, an Active Process Inducing Receptor Competence, Is an Indicator of Platelet Reactivity

Platelet Protease Nexin-1, a Serpin That Strongly Influences Fibrinolysis and Thrombolysis ⬇️

Role of vegetation-associated protease activity in valve destruction in human infective endocarditis.

Single platelets seal neutrophil-induced vascular breaches via GPVI during immune-complex-mediated inflammation in mice.

Structure and properties of clots from fibrinogen Bicêtre II (gamma 308 Asn-->Lys). Increased permeability due to larger pores, thicker fibers, and decreased rigidity

The future of glycoprotein VI as an antithrombotic target.

Topology of protease activities reflects atherothrombotic plaque complexity

Upholding the T cell immune-regulatory function of CD31 inhibits the formation of T/B immunological synapses in vitro and attenuates the development of experimental autoimmune arthritis in vivo

[Antithrombotic recombinant antibodies]